NCT02383212 2020-01-27Study of REGN2810 (Anti-PD-1) in Patients With Advanced MalignanciesRegeneron PharmaceuticalsPhase 1 Completed398 enrolled
NCT01287520 2019-02-25A Study of LY2090314 in Patients With Advanced or Metastatic CancerEli Lilly and CompanyPhase 1 Completed41 enrolled 28 charts
NCT01688791 2015-02-10A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)EndocytePhase 1 Terminated37 enrolled